A Study for Long-term Follow-up of Hemophagocytic Lymphohistiocytosis (HLH) Participants Who Received Treatment With Emapalumab (NI-0501), an Anti-interferon Gamma Monoclonal Antibody
Clinical trial NCT02069899 · COMPLETED
Trial details
- NCT number
- NCT02069899
- Sponsor
- Swedish Orphan Biovitrum
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-04
- Primary completion
- 2021-05-18
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.